Intellectual Property India Publishes Patent Application for 'Combination Of Antibodies, Or Antigen-Binding Fragments Thereof, For The Treatment Of Cancer And Composition Thereof' Filed by Xenothera

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517097109 A) filed by Xenothera, Nantes, France, on Oct. 8, for 'combination of antibodies, or antigen-binding fragments thereof, for the treatment of cancer and composition thereof.'

Inventor(s) include Bassissi, Firas; Ciron, Carine; Duvaux, Odile; and Vanhove, Bernard.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to a combination of antibodies, or antigen-binding fragments thereof, for use in the treatment of a cancer in a human subject in need thereof, the combination comprising at least a first antibody, ...